10x Genomics Inc Ordinary Shares - Class A TXG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Shanghai Precision Diagnostics and Fudan University Shanghai Cancer Center Launch Breast Cancer Biomarker Study Using 10x Genomics' Xenium Platform
10x Genomics Reports Third Quarter 2026 Financial Results
10x Genomics Launches Sentira Single Cell, A New Agentic AI Experience for Chromium Analysis
10x Genomics to Participate in the 2026 Jefferies Global Healthcare Conference
10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 2026
10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers
10x Genomics Announces Sentira, a New Computational Platform to Turn Complex Biological Data Into Experimental Conclusions
10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' Hands
Trading Information
- Previous Close Price
- $58.19
- Day Range
- $54.46–56.35
- 52-Week Range
- $15.19–102.80
- Bid/Ask
- $55.70 / $55.79
- Shares Outstanding
- 131.53M
- Market Cap
- $7.35B
- Volume/Avg
- 1M / 3M
Key Statistics
- Price/Earnings (Normalized)
- 2,326.67
- Price/Sales
- 12.13
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,178
- Website
- https://www.10xgenomics.com
Valuation
Metric | TXG |
|---|---|
Price/Earnings (Normalized) | 2,326.67 |
Price/Book Value | 9.13 |
Price/Sales | 12.13 |
Price/Cash Flow | 86.44 |
Price/Earnings
TXG
Financial Strength
Metric | TXG |
|---|---|
Quick Ratio | 4.52 |
Current Ratio | 5.12 |
Interest Coverage | — |
Quick Ratio
TXG
Profitability
Metric | TXG |
|---|---|
Return on Assets (Normalized) | 0.31% |
Return on Equity (Normalized) | 0.39% |
Return on Invested Capital (Normalized) | −1.45% |
Return on Assets
TXG
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|JwStH@ | LOCK|xqHX | $188B | |||
| Medtronic PLC MDT | LOCK|j>#wNCW | LOCK|G>GW | $132B | |||
| Stryker Corp SYK | LOCK|S?%@>q#b | LOCK|jG | $118B | |||
| Boston Scientific Corp BSX | LOCK|#B&Y^z | LOCK|@QKQ | $64B | |||
| Edwards Lifesciences Corp EW | LOCK|n@^M#yf^ | LOCK|bYfc | $62B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|$dL^fV | LOCK|^>s | $38B | |||
| DexCom Inc DXCM | LOCK|%?GZ#q! | LOCK|tBH<P | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|xwG | LOCK|f$ | $30B | |||
| Steris PLC STE | LOCK|>?@j^CM | LOCK|B&jx> | $26B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|fp><Y$J | LOCK|#HZ | $20B |